129 filings
8-K
PBLA
Panbela Therapeutics, Inc.
15 May 24
Panbela Provides Business Update and Reports Q1 2024 Financial Results
4:14pm
8-K
PBLA
Panbela Therapeutics, Inc.
25 Apr 24
Entry into a Material Definitive Agreement
4:35pm
8-K
PBLA
Panbela Therapeutics, Inc.
22 Apr 24
Panbela Therapeutics Announces Interim Data Analysis for ASPIRE Trial Pushed to Q1 2025
8:02am
8-K
PBLA
Panbela Therapeutics, Inc.
17 Apr 24
Panbela Announces Transfer to OTCQB Market
8:36am
8-K
PBLA
Panbela Therapeutics, Inc.
26 Mar 24
Panbela Provides Business Update and Reports Q4 and FY 2024 Financial Results
4:12pm
8-K
7m5e3v
7 Mar 24
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
6:01am
8-K
lex5qjzfed oqbg68856
15 Feb 24
Regulation FD Disclosure
8:05am
8-K
cq4uhw
13 Feb 24
Departure of Directors or Certain Officers
5:24pm
8-K
uf1qdvy9604 4ultm
1 Feb 24
Panbela Announces Closing of Approximately $9.0 Million Public Offering
7:15am
8-K
azjivfxgt5jdc
29 Jan 24
Panbela Announces Pricing of Approximately $9.0 Million Public Offering
6:21am
8-K
u20pxh 1wmsb
25 Jan 24
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
12:00am
8-K
qlnd8tpu34wx3 9qxcv
19 Jan 24
Material Modifications to Rights of Security Holders
5:20pm
8-K
fasvc
21 Dec 23
Entry into a Material Definitive Agreement
9:25am
8-K
tmak1reeg2d2m y6s7o
21 Dec 23
Submission of Matters to a Vote of Security Holders
6:00am
8-K
gb8imk1r0w9h8
1 Dec 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:15pm
8-K
s2szd4eo99youot
9 Nov 23
Panbela Provides Business Update and Reports Q3 2023 Financial Results
4:10pm
8-K
gz9xb
3 Nov 23
Entry into a Material Definitive Agreement
5:24pm
8-K
87w0f7jd sxqrc7lal1
10 Aug 23
Panbela Provides Business Update and Reports Q2 2023 Financial Results
4:11pm
8-K
5z9oyfz
19 Jul 23
Regulation FD Disclosure
8:02am
8-K
rf8kz7mit8x
10 Jul 23
Regulation FD Disclosure
4:15pm